Marlboro, New Jersey Inpatient Drug Rehab Centers

Francisco U Cruz, M.D. is board certified in General Psychiatry and Addiction Medicine. He has been practicing psychiatry for 14 years and has extensive experience treating mental illness and substance use disorders in a variety of settings including inpatient, outpatient, residential, partial hospitalization, intensive outpatient, and detox levels of care. Dr. Cruz believes in a holistic approach to mental illness incorporating bio-psycho-social-spiritual elements to help patients achieve emotional stability and true inner peace. He strives to provide excellent client centered care and use new treatment modalities to improve the quality of life and overall health of his patients.

Dr. Christodoulou has provided psychiatric emergency services and evaluations for over 20 years. He has taken a special interest in treating children and juveniles, as well as those who suffer from substance use disorders. Dr. Christodoulou is board certified by the American Board of Addiction Medicine and has certifications in both psychiatry and neurology.

Jeffrey A. Berman, MD, FASAM is a Diplomate and Fellow of the American Society of Addiction Medicine. He is the Executive Medical Director of Discovery Institute for Addictive Disorders in Marlboro, NJ and Clinical Assistant Professor of Psychiatry at the Robert Wood Johnson Medical School. He was recruited from Bergen Regional Medical Center, NJ’s largest acute psychiatric hospital, where he served as Director of Chemical Dependency Services to join Discovery Institute in Marlboro. Dr. Berman is a diplomate of the American Board of Psychiatry and Neurology (ABPN) in Adult and Addiction Psychiatry as well as Psychosomatic Medicine. He has been certified by the American Society of Addiction Medicine since 1988 and is Board Certified in Addiction Medicine (ABAM). Dr. Berman’s area of special interest in research and teaching is Pain Management and Co-occurring Opioid Dependence. He is also a strong advocate for Medication Assisted Treatment (MAT) for the chronic persistent mentally ill. Dr. Berman participated in NIDA’s clinical trials of Buprenorphine/Naloxone for treatment of heroin addiction in 2001. Since then he has developed innovative treatment programs for individuals with Co-occurring disorders as well as Substance Use Disorders. Dr. Berman served as Chief of Psychiatry at Fort Leavenworth, KS including the Department of Defense’s US Disciplinary Barracks located at Fort Leavenworth. He recently retired from the US Army Reserve after 22 years of service which included service in Operations Desert Storm and Iraqi Freedom. He is currently the Psychiatric Consultant to the Department of Immigration Health (DIHS), a division of Homeland security. Prior to coming to New Jersey, he served as Medical Director of Gieisinger Health Care’s Marworth chemical dependency center and consultant to pain management centers in New Jersey and Pennsylvania for issues of addiction, pain and co-occurring mood disorders. He has taken an active role in the medical treatment of HIV patients in all of these clinical settings.